PROM1 and Stroke: CD133 + Exo treatment of T2DM-stroke significantly increased arterial blood vessel density, vessel density, myelin density and axon density in the ischemic brain compared to T2DM-stroke mice at 28 days after stroke (Figures 2A-D).